Trials / Conditions / Platinum-resistant Epithelial Ovarian Cancer
Platinum-resistant Epithelial Ovarian Cancer
4 registered clinical trials studyying Platinum-resistant Epithelial Ovarian Cancer.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Withdrawn | A Clinical Study to Observe How Well That BAT8006 Works on Patients With Platinum Resistance Ovarian Cancer NCT06545617 | Bio-Thera Solutions | Phase 1 / Phase 2 |
| Terminated | Maveropepimut-S (MVP-S) and Low-Dose CPA in Patients With Platinum-Resistant Ovarian Cancer NCT05243524 | ImmunoVaccine Technologies, Inc. (IMV Inc.) | Phase 2 |
| Terminated | A Phase 1b Trial of ATRC-101 in Adults With Advanced Solid Malignancies NCT04244552 | Atreca, Inc. | Phase 1 |
| Completed | A Study of the Safety, Tolerability and Effectiveness of Hydroxychloroquine and Itraconazole in Platinum-resis NCT03081702 | University Health Network, Toronto | Phase 1 / Phase 2 |